{"organizations": [], "uuid": "3c46528cde7e8920e727e1373eedab30e73a0c2c", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "", "site_section": "http://www.reuters.com/finance/personal-finance", "section_title": "Wealth, Personal Finance &amp; Money | Reuters.com", "url": "http://www.reuters.com/article/2015/07/17/amounpharmaceuticalco-ma-valeant-pharms-idUSL4N0ZX3QW20150717", "country": "US", "title": "Valeant to buy Egyptian drugmaker Amoun for about $800 mln", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "Valeant to buy Egyptian drugmaker Amoun for about $800 mln | Reuters", "spam_score": 0.0, "site_type": "news", "published": "2015-07-17T16:14:00.000+03:00", "replies_count": 0, "uuid": "3c46528cde7e8920e727e1373eedab30e73a0c2c"}, "author": "Reuters", "url": "http://www.reuters.com/article/2015/07/17/amounpharmaceuticalco-ma-valeant-pharms-idUSL4N0ZX3QW20150717", "ord_in_thread": 0, "title": "Valeant to buy Egyptian drugmaker Amoun for about $800 mln", "locations": [], "entities": {"persons": [], "locations": [], "organizations": []}, "highlightText": "", "language": "english", "persons": [], "text": "July 17 Canadian drugmaker Valeant Pharmaceuticals International Inc said it would buy Egypt's largest drugmaker, Amoun Pharmaceutical, for about $800 million.\nValeant said it expects the acquisition of privately held Amoun to help expand in Middle East and North Africa.\nThe deal also includes additional contingent payments, the company said in a statement. (Reporting by Vidya L Nathan in Bengaluru; Editing by Don Sebastian)", "external_links": [], "published": "2015-07-17T16:14:00.000+03:00", "crawled": "2015-07-17T15:26:24.000+03:00", "highlightTitle": ""}